Figures & data
Figure 1 Study design (in vivo).
![Figure 1 Study design (in vivo).](/cms/asset/7a9820f2-6910-4093-b20c-b4df83dbc6f8/dddt_a_12177768_f0001_c.jpg)
Figure 2 Liver function tests and injury scoring.
Abbreviations: ALT, alanine aminotransferase; Con A, concanavalin A; AST, aspartate aminotransferase; MGL, magnesium isoglycyrrhizinate.
![Figure 2 Liver function tests and injury scoring.](/cms/asset/7e9e2231-5977-4188-87f3-53efc962e724/dddt_a_12177768_f0002_c.jpg)
Figure 3 H&E staining of liver tissue.
Abbreviations: Con A, concanavalin A; MGL, magnesium isoglycyrrhizinate; H&E, hematoxylin and eosin. subsets and ALT levels before and after Con A challenging
![Figure 3 H&E staining of liver tissue.](/cms/asset/2321cec9-7c1b-42f0-a278-51cee6889682/dddt_a_12177768_f0003_c.jpg)
Table 1 The relationship between percentage of CD4+ T-cells subsets and ALT levels before and after Con Achallenging
Figure 4 The subsets of CD4+ T-cells in PBMCs.
Abbreviations: Con A, concanavalin A; MGL, magnesium isoglycyrrhizinate; PBMC, peripheral blood mononuclear cell; SSC, side scatter; FSC, forward scatter.
![Figure 4 The subsets of CD4+ T-cells in PBMCs.](/cms/asset/623b7c6e-dd4a-4bcf-b51f-2b92c087dd40/dddt_a_12177768_f0004_c.jpg)
Figure 5 The subsets of CD4+ T-cells in splenocytes.
Abbreviations: Con A, concanavalin A; MGL, magnesium isoglycyrrhizinate; SSC, side scatter; FSC, forward scatter.
![Figure 5 The subsets of CD4+ T-cells in splenocytes.](/cms/asset/f70bca77-093d-49f5-a56e-b4ae668c2806/dddt_a_12177768_f0005_c.jpg)
Figure 6 The apoptosis of T-cell subsets in thymocytes.
Abbreviations: Con A, concanavalin A; MGL, magnesium isoglycyrrhizinate; SSC, side scatter; FSC, forward scatter.
![Figure 6 The apoptosis of T-cell subsets in thymocytes.](/cms/asset/d09d7303-64b1-494b-9476-46c51a6e682f/dddt_a_12177768_f0006_c.jpg)
Figure 7 The proliferation of cells in the CD4+ T-cell subset before and after MGL administration and/or Con A challenging.
Abbreviations: Ab, antibody; Con A, concanavalin A; MGL, magnesium isoglycyrrhizinate; SSC, side scatter; FSC, forward scatter.
![Figure 7 The proliferation of cells in the CD4+ T-cell subset before and after MGL administration and/or Con A challenging.](/cms/asset/c3d80af2-3c93-4195-8f8b-5c716b635bd0/dddt_a_12177768_f0007_c.jpg)
Figure 8 The inflammasome expression in liver tissue.
Abbreviations: Con A, concanavalin A; MGL, magnesium isoglycyrrhizinate.
![Figure 8 The inflammasome expression in liver tissue.](/cms/asset/847a2f25-e8f2-4899-84e2-f890f72ea168/dddt_a_12177768_f0008_c.jpg)
Figure 9 The possible target in the pathogensis of autoimmune hepatitis.
Abbreviations: APC, antigen presenting cell; MGL, magnesium isoglycyrrhizinate; Con A, concanavalin A; Treg, T regulator cell.
![Figure 9 The possible target in the pathogensis of autoimmune hepatitis.](/cms/asset/6aaf6084-41cd-46fe-93a1-bb628592bd88/dddt_a_12177768_f0009_c.jpg)